StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Recent CTV News Article

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Feb 16, 2021 10:23am

144 Views

Post# 32572533

RE:RE:RE:RE:RE:RE:RE:RE:RE:Recent CTV News Article

Agreed. Would just like some operational updates as we wait for Aristotle and Q4 results.

Biggest opportunity in the company history to pivot and take advantage of Covid revenue and prepare a commercialization of a product years in the development and not a single peep.

Strange?